Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy
Clinical trial NCT04082000 · TERMINATED
Trial details
- NCT number
- NCT04082000
- Sponsor
- Breath of Life International Pharma Ltd
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-15
- Primary completion
- 2020-11-04
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.